The short turnaround from the consortium in bumping its Offer provides a certain degree of determination. At $17.10/share, this is still being done far too cheap. I'd be picking shares up around here.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.